CyTOF: An Emerging Technology for Single-Cell Proteomics in the Mouse

Area of Science:

• Proteomics
• Single-cell analysis
• Biotechnology

Background:

• Single-cell proteome analysis is crucial for understanding biological processes and diseases.
• Mass cytometry (CyTOF) integrates mass spectrometry and flow cytometry for high-parameter single-cell protein analysis.
• Imaging mass cytometry (IMC) extends CyTOF to visualize protein expression in tissues in situ.

Purpose of the Study:

• To describe the CyTOF experimental workflow, including reagent selection, sample preparation, and data analysis.
• To compare CyTOF with flow cytometry, highlighting their respective strengths and weaknesses.
• To review studies utilizing CyTOF and IMC in mouse models of human disease to demonstrate their discovery potential.

Main Methods:

• Mass cytometry (CyTOF) for high-dimensional single-cell protein quantification.
• Imaging mass cytometry (IMC) for in situ tissue proteomic visualization.
• Comparative analysis with traditional flow cytometry.

Main Results:

• CyTOF and IMC can measure 40 to 100 parameters per cell, providing deep proteomic insights.
• These techniques facilitate visualization and analysis of complex cellular and tissue environments.
• Studies in disease models showcase the power of CyTOF and IMC in driving research and therapeutic advancements.

Conclusions:

• CyTOF and IMC are powerful tools for high-dimensional proteomic analysis at the single-cell and tissue levels.
• These technologies significantly enhance the understanding of complex biological pathways and disease mechanisms.
• The application of CyTOF and IMC holds great promise for accelerating discovery research and therapeutic development.